ACE-inhibitor use and the long-term risk of renal failure in diabetes
- 1 March 2006
- journal article
- Published by Elsevier in Kidney International
- Vol. 69 (5) , 913-919
- https://doi.org/10.1038/sj.ki.5000159
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause?Kidney International, 2005
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- Diabetes mellitus and hypertension.Hypertension, 1992
- Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.BMJ, 1991
- Long-Term Effects of Enalapril and Nicardipine on Urinary Albumin Excretion in Patients with Chronic Renal Insufficiency: A 1-Year Follow-UpAmerican Journal of Nephrology, 1991
- Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitusThe Journal of Pediatrics, 1990
- Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.BMJ, 1988
- The need for randomization in the study of intended effectsStatistics in Medicine, 1983
- Diabetic nephropathy: Strategies in prevention and managementKidney International, 1982